Optical enhancement with magnification versus white-light endoscopy for detecting gastric intestinal metaplasia and neoplasia: a randomized controlled trial

Post written by Zhen Li, MD, from the Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China. We conducted a randomized controlled trial comparing optical enhancement combined with magnification endoscopy (ME-OE) with conventional white-light endoscopy (WLE) for detection of gastric intestinal metaplasia (GIM), gastric intraepithelial neoplasia (GIN), and early gastric cancer (EGC). Detection of …

Continue reading Optical enhancement with magnification versus white-light endoscopy for detecting gastric intestinal metaplasia and neoplasia: a randomized controlled trial

Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population

Post written by Mimi C. Tan, MD, MPH, from the Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. Gastric cancer is thought to develop via a progression from gastric atrophy and gastric intestinal metaplasia (GIM) in the setting of Helicobacter pylori infection. Although several risk factors for GIM have …

Continue reading Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population

Screening and surveillance for gastric cancer

Joo Ha Hwang, MD, PhD, from the Harborview Medical Center, University of Washington, in Seattle, Washington, USA reports on this Review article, "Screening and surveillance for gastric cancer in the United States: Is it needed?" This is a review article that examines the published data on risk factors for gastric cancer and methods for gastric …

Continue reading Screening and surveillance for gastric cancer